AVITA Medical to Present at TD Cowen’s 45ᵗʰ Annual Health Care Conference
AVITA Medical (NASDAQ: RCEL), a therapeutic acute wound care company, has announced its upcoming participation in TD Cowen's 45th Annual Health Care Conference. Jim Corbett, the company's Chief Executive Officer, is scheduled to present on Tuesday, March 4, 2025, at 11:50 a.m. Eastern Time.
The presentation will be accessible through a live audio webcast on the Events & Presentations section of AVITA Medical's investor relations website. Interested parties can access the webcast at https://ir.avitamedical.com, and a replay will be made available after the event concludes.
AVITA Medical (NASDAQ: RCEL), un'azienda specializzata nella cura terapeutica delle ferite acute, ha annunciato la sua prossima partecipazione al 45° Annual Health Care Conference di TD Cowen. Jim Corbett, il CEO dell'azienda, è programmato per presentare martedì 4 marzo 2025, alle 11:50 ora orientale.
La presentazione sarà accessibile tramite un webcast audio in diretta nella sezione Eventi e Presentazioni del sito web delle relazioni con gli investitori di AVITA Medical. Le parti interessate possono accedere al webcast su https://ir.avitamedical.com, e una registrazione sarà disponibile dopo la conclusione dell'evento.
AVITA Medical (NASDAQ: RCEL), una empresa de cuidado terapéutico de heridas agudas, ha anunciado su próxima participación en la 45ª Conferencia Anual de Atención Médica de TD Cowen. Jim Corbett, el director ejecutivo de la empresa, está programado para presentar el martes 4 de marzo de 2025, a las 11:50 a.m. hora del este.
La presentación será accesible a través de un webcast de audio en vivo en la sección de Eventos y Presentaciones del sitio web de relaciones con inversores de AVITA Medical. Las partes interesadas pueden acceder al webcast en https://ir.avitamedical.com, y se hará disponible una repetición después de que concluya el evento.
AVITA Medical (NASDAQ: RCEL)는 치료적 급성 상처 치료 회사로서 TD Cowen의 제45회 연례 의료 회의에 참여할 예정이라고 발표했습니다. Jim Corbett 회사의 CEO가 2025년 3월 4일 화요일 동부 표준시 기준 오전 11시 50분에 발표할 예정입니다.
발표는 AVITA Medical의 투자자 관계 웹사이트의 이벤트 및 발표 섹션에서 라이브 오디오 웹캐스트를 통해 접근할 수 있습니다. 관심 있는 분들은 https://ir.avitamedical.com에서 웹캐스트에 접속할 수 있으며, 이벤트가 종료된 후 다시 볼 수 있는 재생본이 제공될 것입니다.
AVITA Medical (NASDAQ: RCEL), une entreprise spécialisée dans les soins thérapeutiques des plaies aiguës, a annoncé sa prochaine participation à la 45ème Conférence Annuelle de Soins de Santé de TD Cowen. Jim Corbett, le PDG de l'entreprise, est prévu pour présenter le mardi 4 mars 2025, à 11h50, heure de l'Est.
La présentation sera accessible via un webcast audio en direct dans la section Événements et Présentations du site web des relations avec les investisseurs d'AVITA Medical. Les parties intéressées peuvent accéder au webcast à l'adresse https://ir.avitamedical.com, et un enregistrement sera disponible après la fin de l'événement.
AVITA Medical (NASDAQ: RCEL), ein Unternehmen für therapeutische akute Wundversorgung, hat seine bevorstehende Teilnahme an der 45. jährlichen Gesundheitskonferenz von TD Cowen angekündigt. Jim Corbett, der CEO des Unternehmens, wird voraussichtlich am Dienstag, den 4. März 2025, um 11:50 Uhr Eastern Time präsentieren.
Die Präsentation wird über ein Live-Audio-Webcast im Bereich Veranstaltungen und Präsentationen auf der Investor Relations-Website von AVITA Medical zugänglich sein. Interessierte können den Webcast unter https://ir.avitamedical.com abrufen, und eine Wiederholung wird nach Abschluss der Veranstaltung verfügbar sein.
- None.
- None.
VALENCIA, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced that Jim Corbett, Chief Executive Officer, will present at TD Cowen’s 45th Annual Health Care Conference on Tuesday, March 4, 2025, at 11:50 a.m. Eastern Time.
A live audio webcast of the presentation will be accessible under the Events & Presentations section of the Company's website at https://ir.avitamedical.com. A replay of the webcast will be available following the conclusion of the event.
About AVITA Medical, Inc.
AVITA Medical® is a leading therapeutic acute wound care company delivering transformative solutions. Our technologies are designed to optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of our platform is the RECELL® System, approved by the U.S. Food and Drug Administration for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin™ Cells, offering an innovative solution for improved clinical outcomes at the point-of-care. In the U.S., AVITA Medical also holds the exclusive rights to market, sell, and distribute Cohealyx™, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm®, a biosynthetic wound matrix.
In international markets, the RECELL System is approved to promote skin healing in a wide range of applications including burns and full-thickness skin defects. The RECELL System, excluding RECELL GO®, is TGA-registered in Australia, has received CE mark approval in Europe, and has PMDA approval in Japan.
To learn more, visit www.avitamedical.com.
Authorized for release by the Chief Financial Officer of AVITA Medical, Inc.
FAQ
When is AVITA Medical (RCEL) presenting at TD Cowen's Healthcare Conference 2025?
How can investors watch AVITA Medical's (RCEL) TD Cowen conference presentation?
Will there be a replay available of AVITA Medical's (RCEL) TD Cowen presentation?
Who is presenting for AVITA Medical (RCEL) at the TD Cowen Healthcare Conference?
